| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.6M | -49.6% |
| R&D Expense | $64.3M | +36.5% |
| SG&A Expense | $22.2M | +23.2% |
| Operating Income | -$70.9M | -107.7% |
| Income Tax | $0 | — |
| Net Income | -$68.8M | -101.6% |
| EPS (Basic) | -$1.90 | -55.7% |
| EPS (Diluted) | -$1.90 | -55.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $59.9M | -74.2% |
| Short-term Investments | $97.0M | — |
| Current Assets | $160.0M | -32.3% |
| Total Assets | $172.3M | -30.5% |
| Current Liabilities | $21.5M | -20.9% |
| Total Liabilities | $25.3M | -36.8% |
| Stockholders' Equity | $147.0M | -29.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$74.1M | -23.0% |
| Capital Expenditures | $1.4M | -18.7% |
| Investing Cash Flow | -$99.3M | -5541.1% |
| Financing Cash Flow | $1.1M | -99.2% |
| Free Cash Flow | -$75.5M | -21.8% |